News Conference News CRT 2025 STEMI Revascularization Times All Over the Map: GWTG Registry L.A. McKeown March 14, 2025
News Conference News CRT 2025 ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions L.A. McKeown March 14, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2024 CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care L.A. McKeown March 20, 2024
News Conference News CRT 2024 Comprehensive Radiation Shield Sharply Cuts Operator Exposure L.A. McKeown March 19, 2024
News Conference News CRT 2024 SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI L.A. McKeown March 15, 2024
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Conference News CRT 2024 Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction L.A. McKeown March 12, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News CRT 2023 Small Study Highlights the Serious Nature of Coronary Stent Infections Yael L. Maxwell March 04, 2023
News Conference News CRT 2023 New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR Yael L. Maxwell March 03, 2023
News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Conference News CRT 2023 ‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes Yael L. Maxwell February 27, 2023
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients Todd Neale March 01, 2022
News Conference News CRT 2021 Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8 Yael L. Maxwell March 18, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021